| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 27, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 200,000 | $2.61 | $522,000.00 | -2.3% | |
| May 22, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 1,750,000 | $3.10 | $5,428,500.00 | -16.9% | |
| May 18, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 1,943,308 | $2.92 | $5,673,062.36 | -15.8% | |
| May 13, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 3,406,692 | $2.92 | $9,962,929.04 | -21.7% | |
| May 8, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 250,000 | $2.53 | $632,000.00 | -1.6% | |
| May 5, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 2,650,000 | $2.68 | $7,089,425.31 | -14.2% | |
| Apr 30, 2020 | VXRT Vaxart, Inc. | Director, 10% Owner | Sell | 6,600,000 | $3.05 | $20,122,351.10 | -26.2% | |
| Apr 27, 2020 | AYTU Aytu Biopharma, Inc | Director | Sale+OE | 5,108,921 | $1.82 | $9,298,236.22 | -100% | |
| Apr 3, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 4,280 | $2.16 | $9,244.80 | +0.5% | |
| Mar 31, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 111,914 | $2.37 | $265,345.68 | +15.6% |